A study to evaluate the effect of Jeevantyadi Yamaka enema therapy in irregular and scanty menstrual cycle/ Oligomenorrhea
- Conditions
- Health Condition 1: N915- Oligomenorrhea, unspecified
- Registration Number
- CTRI/2024/07/070060
- Lead Sponsor
- Dr Aishwarya B
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Subjects between the age group of 20- 40 years.
2)Subjects irrespective of marital status and parity.
3)Subjects presenting the classical symptoms of Artavakshaya.
4)Subjects with symptoms of Oligomenorrhea.
5)Subjects suffering from Artavakshaya for more than 2 cycles.
6)Subjects with spotting/bleeding less than 2 days.
7)Subjects with or without pain during menstruation.
8)Subjects after 3 months of withdrawal of oral contraceptive pills and removal of intra uterine contraceptive device.
9)Subjects willing to sign the consent form.
1)Subjects who are pregnant and lactating mothers.
2)Subjects with hemoglobin less than 10g%.
3)Subjects with congenital malformation of uterus.
4)Subjects with known case of hemorrhoids, fistula, fissures.
5)Subjects with known case of chronic systemic illness and malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Significant decrease in symptoms of Artavakshaya with special reference to Oligomenorrhea based on assessment criteria. <br/ ><br>a.Interval between two cycles <br/ ><br>b.Amount of menstrual bleeding loss. <br/ ><br>c.Duration of menstrual flow <br/ ><br>d.Intensity of pain during menstruation. <br/ ><br>e.Assessment of pain- Grading by VMS. <br/ ><br> <br/ ><br>2.The efficacy of Jeevantyadi Yamaka Matra Basti will be established in the treatment of Artavakshaya. <br/ ><br>Efficacy shall be assessed based on assessment criteria mentioned above.Timepoint: Pre assessment-0th day <br/ ><br>1st assessment-1st cycle after treatment- 1month <br/ ><br>Follow up-2nd cycle without treatment- 2 month
- Secondary Outcome Measures
Name Time Method 1.Generation of in- depth analysed data on the different aspect of the disease. <br/ ><br>2.Generation of data on possible unexpected drug reaction. <br/ ><br>Timepoint: 1 year